Drug Development Pathway: IND, NDA & ANDA for Pharmaceutical Product Development
Align pharmaceutical R&D strategy with IND, NDA, and ANDA regulatory pathways to ensure compliant development and accelerate approval timelines.
This training program provides a structured understanding of the drug development pathway with focus on IND, NDA, and ANDA from an R&D perspective. It connects preclinical research, clinical development, CMC strategy, and regulatory documentation to ensure smooth progression from discovery to commercialization. Participants will gain clarity on aligning development activities with submission requirements.
Course Content
Meet Your Instructor
Offered by Huksa, this L&D program is led by elite industry veterans—CXOs and Functional Heads with 25+ years of deep-domain expertise. You have the flexibility to customize the curriculum, select your preferred expert, and align the program to your organization’s specific objectives. Connect with the Huksa team to explore our array of top-tier trainers available for this course!
₹120,000.00
This course includes:
- Lessons 8
- Topics 27
- Duration 2-3 Days
- Quizzes 0
- Language English
Share
Report
